KALO yields 666666.67% · FCPT yields 6.05%● Live data
📍 KALO pulled ahead of the other in Year 1
Combined, KALO + FCPT cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of KALO + FCPT for your $10,000?
Kallo Inc., together with its subsidiaries, focuses on developing medical information technology software. The company's products in development include Electronic Medical Records (EMR) Integration Engine, a software, which connects various other applications in or outside a hospital/clinic with the EMR system; Communicable and Infectious Disease Information Management System, an Internet-based solution for monitoring and managing communicable and infectious disease information; and Clinical-Care Globalization, a clinical-care globalization technology. Its products also include MC-Telehealth, a mobile clinic with telehealth system technology; Kallo Integrated Delivery System (KIDS), a technology and process framework that defines and describes the component parts of the various products and services; and KIDS Global Tele-Health Ecosystems, a Tele-health Program that encompasses various technologies and administrative processes needed to deliver virtual medical care, health promotion/prevention, and other patient education to KIDS patients. The company was formerly known as Diamond Technologies Inc. The company was incorporated in 2006 and is headquartered in Toronto, Canada.
Full KALO Calculator →FCPT, headquartered in Mill Valley, CA, is a real estate investment trust primarily engaged in the acquisition and leasing of restaurant properties. The Company seeks to grow its portfolio by acquiring additional real estate to lease, on a net basis, for use in the restaurant and retail industries.
Full FCPT Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.